Krupnik, LeonardAvaro, JonathanLiebi, MarianneAnaraki, Neda IranpourKohlbrecher, JoachimSologubenko, AllaHandschin, StephanRzepiela, Andrzej J.Appel, ChristianTotu, TiberiuBlanchet, Clement E.Alston, Amy E. BartonDigigow, ReinaldoPhilipp, ErikFluehmann, BeatSilva, Bruno F. B.Neels, AntoniaWick, Peter2024-06-052024-06-052024-06-052024-04-0110.1016/j.jconrel.2024.02.044https://infoscience.epfl.ch/handle/20.500.14299/208402WOS:001225857800001Intravenous (IV) iron-carbohydrate complexes are widely used nanoparticles (NPs) to treat iron deficiency anaemia, often associated with medical conditions such as chronic kidney disease, heart failure and various inflammatory conditions. Even though a plethora of physicochemical characterisation data and clinical studies are available for these products, evidence-based correlation between physicochemical properties of ironcarbohydrate complexes and clinical outcome has not fully been elucidated yet. Studies on other metal oxide NPs suggest that early interactions between NPs and blood upon IV injection are key to understanding how differences in physicochemical characteristics of iron-carbohydrate complexes cause variance in clinical outcomes. We therefore investigated the core-ligand structure of two clinically relevant iron-carbohydrate complexes, iron sucrose (IS) and ferric carboxymaltose (FCM), and their interactions with two structurally different human plasma proteins, human serum albumin (HSA) and fibrinogen, using a combination of cryo-scanning transmission electron microscopy (cryo-STEM), x-ray diffraction (XRD), small-angle x-ray scattering (SAXS)Physical SciencesLife Sciences & BiomedicineIron Deficiency AnaemiaNanoparticles (Nps)Non -Biological Complex Drugs (Nbcds)Iron -Carbohydrate ComplexesSmall -Angle X-Ray Scattering (Saxs)Small -Angle Neutron Scattering (Sans)text::journal::journal article::research article